...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >CD8(+) CD103(+) Tumor-Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
【24h】

CD8(+) CD103(+) Tumor-Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients

机译:CD8(+)CD103(+)肿瘤浸润淋巴细胞是肿瘤特定的组织驻留性记忆T细胞,是肺癌患者生存的预后因素。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We had previously demonstrated the role of CD103 integrin on lung tumor-infiltrating lymphocyte (TIL) clones in promoting specific TCR-mediated epithelial tumor cell cytotoxicity. However, the contribution of CD103 on intratumoral T cell distribution and functions and the prognosis significance of TIL subpopulations in non-small cell lung carcinoma (NSCLC) have thus far not been systematically addressed. In this study, we show that an enhanced CD103(+) TIL subset correlates with improved early stage NSCLC patient survival and increased intraepithelial lymphocyte infiltration. Moreover, our results indicate that CD8(+) CD103(+) TIL, freshly isolated from NSCLC specimens, display transcriptomic and phenotypic signatures characteristic of tissue-resident memory T cells and frequently express PD-1 and Tim-3 checkpoint receptors. This TIL subset also displays increased activation-induced cell death and mediates specific cytolytic activity toward autologous tumor cells upon blockade of the PD-1-PD-L1 interaction. These findings emphasize the role of CD8(+) CD103(+) tissue-resident memory T cells in promoting intratumoral CTL responses and support the rationale for using anti-PD-1 blocking Ab to reverse tumor-induced T cell exhaustion in NSCLC patients.
机译:我们以前已经证明CD103整联蛋白在肺肿瘤浸润淋巴细胞(TIL)克隆中在促进特异性TCR介导的上皮肿瘤细胞的细胞毒性中的作用。然而,CD103对肿瘤内T细胞分布和功能的贡献以及非小细胞肺癌(NSCLC)中TIL亚群的预后意义迄今尚未得到系统的研究。在这项研究中,我们表明,增强的CD103(+)TIL子集与早期NSCLC患者生存期的改善和上皮内淋巴细胞浸润的增加相关。此外,我们的结果表明,刚从NSCLC标本中分离的CD8(+)CD103(+)TIL显示出组织驻留记忆T细胞的转录组和表型特征,并经常表达PD-1和Tim-3检查点受体。该TIL子集还显示出增加的激活诱导的细胞死亡,并在阻断PD-1-PD-L1相互作用时介导对自体肿瘤细胞的特异性溶细胞活性。这些发现强调了CD8(+)CD103(+)组织驻留记忆T细胞在促进肿瘤内CTL反应中的作用,并支持使用抗PD-1阻断Ab逆转NSCLC患者肿瘤诱导的T细胞衰竭的原理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号